Pacific Biosciences of California (PACB) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 8.00
(+444.22%)
Based on the Pacific Biosciences of California stock forecast from 11 analysts, the average analyst target price for Pacific Biosciences of California is USD 8.00 over the next 12 months. Pacific Biosciences of California’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Pacific Biosciences of California is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Pacific Biosciences of California’s stock price was USD 1.47. Pacific Biosciences of California’s stock price has changed by -5.16% over the past week, -60.48% over the past month and -85.27% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for PACB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
